Health
Study finds short window for donating convalescent plasma to COVID-19 patients – Medical Xpress
The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the Food and Drug Administration…
The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the Food and Drug Administration in August 2020, is within 60 days of the onset of symptoms, according to a new Penn State-led study. The research also reveals that the ideal convalescent plasma donor is a recovered COVID-19 patient who is older than 30 and whose illness had been severe.
“Millions of individuals worldwide have recovered from COVID-19 and may be…
-
General22 hours agoAustralian economy still vulnerable to US bond turmoil
-
Business18 hours agoWhat I’d buy before the ASX rebounds: 3 high-conviction share picks
-
Noosa News6 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
Business20 hours ago2 ASX 200 shares that could be top buys for growth